Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens

K Grancharov1, H Engelberg, Z Naydenova

  • 1Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia.

Archives of Toxicology
|January 26, 2002
PubMed

Insights

Tannic acid and griseofulvin significantly inhibit UDP-glucuronosyltransferase (UGT) enzymes, which are crucial for drug metabolism. These natural compounds can block the glucuronidation of various substrates, impacting how the body processes toxins and medications.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Toxicology

Background:

  • UDP-glucuronosyltransferase (UGT) enzymes are critical for the detoxification and elimination of xenobiotics and endogenous compounds.
  • Dietary compounds and drugs can modulate UGT activity, influencing drug efficacy and toxicity.
  • Understanding UGT inhibition is vital for predicting drug-drug interactions and assessing the safety of natural products.

Purpose of the Study:

  • To investigate the inhibitory potential of eight naturally occurring toxic compounds on rat liver microsomal UDP-glucuronosyltransferase (UGT) activity.
  • To characterize the inhibition kinetics of potent inhibitors, tannic acid and griseofulvin, against specific UGT substrates.

Main Methods:

  • Rat liver microsomes were used to assess UGT activity with 1-naphthol (1-NA), phenolphthalein (PPh), and 4-nitrophenol (4-NP) as substrates.
  • Inhibition assays were performed at various concentrations of tested compounds, including tannic acid and griseofulvin.
  • Kinetic studies were conducted to determine the type of inhibition and inhibition constants (Ki) for potent inhibitors.

Main Results:

  • Tannic acid and griseofulvin exhibited strong inhibition of UGT activity. At 1 mM, both compounds completely suppressed the glucuronidation of 1-NA and PPh, respectively.
  • Even at 50 microM, tannic acid caused nearly 50% inhibition of 1-NA conjugation.
  • UGT isoforms metabolizing 4-NP were generally less sensitive, except to griseofulvin. Kinetic analysis revealed uncompetitive inhibition by tannic acid and non-competitive/mixed-type inhibition by griseofulvin.

Conclusions:

  • Tannic acid and griseofulvin are potent inhibitors of specific rat liver UGT isoforms.
  • These findings highlight the potential for dietary components and certain drugs to interfere with drug metabolism via UGT inhibition.
  • Further research is warranted to assess the in vivo implications of tannic acid and griseofulvin on drug disposition and toxicity.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).